| Elie G Dib, MD | |
|
5301 E Huron River Dr, Ste C-139, Ypsilanti, MI 48197-1051 | |
| (734) 712-1000 | |
| (734) 712-1012 |
| Full Name | Elie G Dib |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 25 Years |
| Location | 5301 E Huron River Dr, Ypsilanti, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174576219 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Joseph Mercy Hospital | Ann arbor, MI | Hospital |
| St Joseph Mercy Chelsea | Chelsea, MI | Hospital |
| Saint Joseph Mercy Livingston Hospital | Howell, MI | Hospital |
| St Joe Mercy Hospital System Livonia | Livonia, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Iha Health Services Corporation | 2466351440 | 911 |
News Archive
Eukaryotic cells employ multiple strategies of checkpoint signaling and DNA repair mechanisms to monitor and repair damaged DNA.
Baxter International Inc. today announced initiation of a Phase III clinical trial to evaluate the safety and effectiveness of BAX 111, Baxter's investigational recombinant von Willebrand factor (rVWF), for the treatment and prevention of bleeding episodes in patients with von Willebrand disease.
Programs that encourage communities to get more active are one strategy for stemming the global tide of obesity. Yet, a new review of studies says the evidence backing the effectiveness of these programs is poor.
Veteran cancer reseacher Prof. Emeritus Alexander Levitzki of Hebrew University of Jerusalem says new findings show link between colorectal cancer and melanoma drug treatment knoqwn as "NT157" in two recently published studies in journal, "Ocogene."
The demand for radiotherapy across all European countries will increase by an average of 16% between 2012 and 2025, with the highest expected increase being for prostate cancer cases (24%), according to a new study published in Radiotherapy and Oncology.
› Verified 4 days ago
| Entity Name | Iha Health Services Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457408965 PECOS PAC ID: 2466351440 Enrollment ID: O20040108000355 |
News Archive
Eukaryotic cells employ multiple strategies of checkpoint signaling and DNA repair mechanisms to monitor and repair damaged DNA.
Baxter International Inc. today announced initiation of a Phase III clinical trial to evaluate the safety and effectiveness of BAX 111, Baxter's investigational recombinant von Willebrand factor (rVWF), for the treatment and prevention of bleeding episodes in patients with von Willebrand disease.
Programs that encourage communities to get more active are one strategy for stemming the global tide of obesity. Yet, a new review of studies says the evidence backing the effectiveness of these programs is poor.
Veteran cancer reseacher Prof. Emeritus Alexander Levitzki of Hebrew University of Jerusalem says new findings show link between colorectal cancer and melanoma drug treatment knoqwn as "NT157" in two recently published studies in journal, "Ocogene."
The demand for radiotherapy across all European countries will increase by an average of 16% between 2012 and 2025, with the highest expected increase being for prostate cancer cases (24%), according to a new study published in Radiotherapy and Oncology.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Elie G Dib, MD 24 Frank Lloyd Wright Dr, Po Boc 0446 Lobby J, Ann Arbor, MI 48105-9484 Ph: (734) 747-6766 | Elie G Dib, MD 5301 E Huron River Dr, Ste C-139, Ypsilanti, MI 48197-1051 Ph: (734) 712-1000 |
News Archive
Eukaryotic cells employ multiple strategies of checkpoint signaling and DNA repair mechanisms to monitor and repair damaged DNA.
Baxter International Inc. today announced initiation of a Phase III clinical trial to evaluate the safety and effectiveness of BAX 111, Baxter's investigational recombinant von Willebrand factor (rVWF), for the treatment and prevention of bleeding episodes in patients with von Willebrand disease.
Programs that encourage communities to get more active are one strategy for stemming the global tide of obesity. Yet, a new review of studies says the evidence backing the effectiveness of these programs is poor.
Veteran cancer reseacher Prof. Emeritus Alexander Levitzki of Hebrew University of Jerusalem says new findings show link between colorectal cancer and melanoma drug treatment knoqwn as "NT157" in two recently published studies in journal, "Ocogene."
The demand for radiotherapy across all European countries will increase by an average of 16% between 2012 and 2025, with the highest expected increase being for prostate cancer cases (24%), according to a new study published in Radiotherapy and Oncology.
› Verified 4 days ago
Bretton Lee Schloesser, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 5301 E Huron River Dr, Ypsilanti, MI 48197 Phone: 734-712-8676 | |
Dr. Kelly Perry Apple, M.D. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 5301 E Huron River Dr, Ypsilanti, MI 48197 Phone: 734-712-8676 Fax: 734-712-3855 | |
Rajiv Doddamani, Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 5333 Mcauley Dr, Suite 4001, Ypsilanti, MI 48197 Phone: 734-834-4270 | |
Dr. James Paolo Purtell, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 5333 Mcauley Dr, Suite 2111, Ypsilanti, MI 48197 Phone: 734-712-5552 | |
Kory Ashton Strong, DO Hematology & Oncology Medicare: Medicare Enrolled Practice Location: Iha Hospital Medicine Services, 5301 E Huron River Drive, Ypsilanti, MI 48197 Phone: 734-712-8676 | |
Michael Sanson, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 5361 Mcauley Dr, Ypsilanti, MI 48197 Phone: 734-712-1300 Fax: 734-222-3665 | |
Dr. Stephanie Joy-kraftson Hoffman, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: Iha Hematology Oncology, 5303 Elliott Drive, Suite 210, Ypsilanti, MI 48197 Phone: 734-712-1000 Fax: 734-712-1012 |